SlideShare a Scribd company logo
1 of 31
Nephrotic Syndrome..…(NS)
Nephrotic syndrome
Nephrotic syndrome (NS) results from increased
permeability of Glomeulrar basement membrane
(GBM) to plasma protein.
It is clinical and laboratory syndrome
characterized by massive proteinuria, which
lead to hypoproteinemia ( hypo-albuminemia),
hyperlipidemia and pitting edema.
(4-increase, 1-decrease).
Nephrotic Criteria:-
*Massive proteinuria:
qualitative proteinuria: 3+ or 4+,
quantitative proteinuria : more than 40 mg/m2/hr in
children (selective).
*Hypo-proteinemia :
total plasma proteins < 5.5g/dl and serum albumin : <
2.5g/dl.
*Hyperlipidemia:
serum cholesterol : > 5.7mmol/L
*Edema: pitting edema in different degree
Nephritic Criteria
 -Hematuria: RBC in urine (gross hematuria)
 -Hypertension:
 ≥130/90 mmHg in school-age children
 ≥120/80 mmHg in preschool-age children
 ≥110/70 mmHg in infant and toddler’s children
 -Azotemia(renal insufficiency):
Increased level of serum BUN
Classification:
 A-Primary Idiopathic NS (INS): majority
The cause is still unclear up to now. Recent 10 years
,increasing evidence has suggested that INS may result
from a primary disorder of T– cell function.
Accounting for 90% of NS in child. mainly discussed.
 B-Secondary NS:
NS resulted from systemic diseases, such as anaphylactoid
purpura , systemic lupus erythematosus, HBV infection.
 C-Congenital NS: rare
*1st 3monthe of life ,only treatment renal transplantation
Secondary NS
 Drug,Toxic,Allegy: mercury, snake venom, vaccine, pellicillamine,
Heroin, gold, NSAID, captopril, probenecid, volatile hydrocarbons
 Infection: APSGN, HBV, HIV, shunt nephropathy, reflux
nephropathy, leprosy, syphilis, Schistosomiasis, hydatid disease
 Autoimmune or collagen-vascular diseases: SLE, Hashimoto’s
thyroiditis,, HSP, Vasculitis
 Metabolic disease: Diabetes mellitus
 Neoplasma: Hodgkin’s disease, carcinoma ( renal cell, lung,
neuroblastoma, breast, and etc)
 Genetic Disease: Alport syn, Sickle cell disease, Amyloidosis,
Congenital nephropathy
 Others: Chronic transplant rejection, congenital nephrosclerosis
Idiopathic NS (INS): Pathology:-
 Minimal Change Nephropathy (MCN): <80%
The glomeruli appear normal basically Under Light
microscopy, and Under Immunofluorescence
*under Electron microscopy – fusion of the foot
processes of the podocytes
 (2) Non—MCN: <20%
*Mesangial proliferative glomerulonephritis
(MsPGN): about 10%
*Focal segmental glomerulosclerosis (FSGS): 5%
*Membranous Nephropathy (MN) : 2%
*Membrane proliferative glomerulonephritis
 (MPGN) : 1%
 *Others: rare,Cresent glomerulonephritis
 NB:-
 *Nephrotic syndrome is 15 times more common in
children than in adults.
 *Most cases of primary nephrotic syndrome are in
children and are due to minimal-change disease. The
age at onset varies with the type of nephrotic
syndrome.
Pathophysiology:
The Main Trigger Of primary Nephrotic Syndrome
and Fundamental and highly important change of
pathophysiology :-
Proteinuria
Pathogenesis of Proteinuria:-
 Increase glomerular permeability for proteins due to loss of
negative charged glycoprotein
 Degree of protineuria:-
 Mild less than 0.5g/m2/day
 Moderate 0.5 – 2g/m2/day
 Sever more than 2g/m2/day
 Type of proteinuria:-
 A-Selective proteinuria: where proteins of low molecular
weight .such as albumin, are excreted more readily than
protein of HMW
 B-Non selective :
 LMW+HMW are lost in urine
pathogenesis of hypoalbuminemia
*Due to hyperproteinuria----- Loss of plasma
protein in urine mainly the albumin.
*Increased catabolism of protein during acute
phase.
pathogenesis of hyperlipidemia:-
*Response to Hypoalbuminemia → reflex to liver --→
synthesis of generalize protein ( including
lipoprotein ) and lipid in the liver ,the lipoprotein
high molecular weight no loss in urine →
hyperlipidemia
*Diminished catabolism of lipoprotein
pathogenesis of edema:-
 *Reduction plasma colloid osmotic pressure↓
secondary to hypoalbuminemia Edema and
hypovolemia
 *Intravascular volume↓ antidiuretic hormone (ADH
) and aldosterone(ALD)  water and sodium
retention Edema
 *Intravascular volume↓ glomerular filtration rate
 (GFR)↓ water and sodium retention  Edema
How many pathological types causes
nephrotic syndrome?
Clinical Manifestation:-
IN MCNS , The male preponderance of 2:1
: 1.Main manifestations:
Edema (varying degrees) is the common symptom
Local edema: edema in face , around eyes( Periorbital swelling) , in
lower extremities.
Generalized edema (anasarca), edema in penis and scrotum.
2-Non-specific symptoms:
Fatigue and lethargy
loss of appetite, nausea and vomiting ,abdominal pain , diarrhea
body weight increase, urine output decrease
pleural effusion (respiratory distress)
Investigations:-
 1-Urine analysis:-
A-Proteinuria :
b-24 urine collection for protein
>40mg/m2/hr for children
c- volume: oliguria (during stage of edema formation)
d-Microscopically:-
microscopic hematuria 20%, large number of hyaline cast
Investigations:-
 2-Blood:
 A-serum protein: decrease >5.5gm/dL , Albumin levels are
low (<2.5gm/dL).
 B-Serum cholesterol and triglycerides:
Cholesterol >5.7mmol/L (220mg/dl).
 C-- ESR↑>100mm/hr during activity phase
 .
 3.Serum complemen: Vary with clinical type.
 4.Renal function
Complications of NS:-
1-Infections:Infections is a major complication in children with
NS. It frequently trigger relapses.
Nephrotic pt are liable to infection because :
A-loss of immunoglobins in urine.
B-the edema fluid act as a culture medium.
C-use immunosuppressive agents.
D- malnutrition
The common infection : URI, peritonitis, cellulitis and UTI
may be seen.
Organisms: encapsulated (Pneumococci, H.influenzae),
Gram negative (e.g E.coli
Complication …
Vaccines in NS;-
polyvalent pneumococcal vaccine (if not previously
immunized) when the child is in remission and off daily
prednisone therapy.
Children with a negative varicella titer should be given varicella
vaccine.
Complication…..
 2-Hypercoagulability (Thrombosis).
 Hypercoagulability of the blood leading to venous or arterial
thrombosis:
 Hypercoagulability in Nephrotic syndrome caused by:
 1-Higher concentration of I,II, V,VII,VIII,X and fibrinogen
 2- Lower level of anticoagulant substance: antithrombin III
 3-decrease fibrinolysis.
 4-Higher blood viscosity
 5- Increased platelet aggregation
 6- Overaggressive diuresis
 3-ARF: pre-renal and renal
 4- cardiovascular disease :-Hyperlipidemia, may be a risk
factor for cardiovascular disease.
 5-Hypovolemic shock
 6-Others: growth retardation, malnutrition,
 adrenal cortical insufficiency
Management of NS:
 General (non-specific )
 *Corticosteroid therapy
General therapy:-
 Hospitalization:- for initial work-up and evaluation of
treatment.
 Activity: usually no restriction , except
 massive edema,heavy hypertension and infection.
 Diet
Hypertension and edema: Low salt diet (<2gNa/ day) only
during period of edema or salt-free diet.
Severe edema: Restricting fluid intake
 Avoiding infection: very important.
 Diuresis: Hydrochlorothiazide (HCT) :2mg/kg.d
 Antisterone : 2~4mg/kg.d
 Dextran : 10~15ml/kg , after 30~60m,
 followed by Furosemide (Lasix) at 2mg/kg .
Induction use of albumin:-
 Albumin + Lasix (20 % salt poor)
 1-Severe edema
 2-Ascites
 3-Pleural effusion
 4-Genital edema
 5-Low serum albumin
Corticosteroid—prednisone therapy:-
Prednisone tablets at a dose of 60 mg/m2/day (maximum
daily dose, 80 mg divided into 2-3 doses) for at least 4
consecutive weeks.
After complete absence of proteinuria, prednisone dose
should be tapered to 40 mg/m2/day given every other
day as a single morning dose.
The alternate-day dose is then slowly tapered and
discontinued over the next 2-3 mo.
Treatment of relapse in NS:
Many children with nephrotic syndrome will experience
at least 1 relapse (3-4+proteinuria plus edema).
daily divided-dose prednisone at the doses noted earlier
(where he has the relapse) until the child enters
remission (urine trace or negative for protein for 3
consecutive days).
The pred-nisone dose is then changed to alternate-day
dosing and tapered over 1-2 mo.
Side Effects With Long Term Use of
Steroids “Steroid toxicity
 hyperglycemia
 myopathy
 peptic ulcer
 poor healing of wound.
 Hirsutism
 Thromboembolism
-Stunted growth
Cataracts
-Osteoporosis
- Cushing syndrome features
-Adrenal gland suppression
Alternative agent:-
 When can be used:
 Steroid-dependent patients, frequent relapsers, and steroid-
resistant patients.
 Cyclophosphamide Pulse steroids
 Cyclosporin A
 Tacrolimus
 Microphenolate
 THE END….
THANK YOU….

More Related Content

Similar to Nephrotic_Syndrome[1].pptx

Nephrosis 2009,
Nephrosis 2009,Nephrosis 2009,
Nephrosis 2009,
Deep Deep
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
Abhay Mange
 
Nephrotic syndrome 1
Nephrotic syndrome 1Nephrotic syndrome 1
Nephrotic syndrome 1
nazurah
 
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptxnephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
mas1011422
 
Approach to glomerular disease.pkuwkkptx
Approach to glomerular disease.pkuwkkptxApproach to glomerular disease.pkuwkkptx
Approach to glomerular disease.pkuwkkptx
Hussen39
 

Similar to Nephrotic_Syndrome[1].pptx (20)

Nephrosis 2009,
Nephrosis 2009,Nephrosis 2009,
Nephrosis 2009,
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
 
Nephroticsyndrome
NephroticsyndromeNephroticsyndrome
Nephroticsyndrome
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Nephrotic syndrome - Medicine - RDT
Nephrotic syndrome - Medicine - RDTNephrotic syndrome - Medicine - RDT
Nephrotic syndrome - Medicine - RDT
 
Nephrotic syndrome 1
Nephrotic syndrome 1Nephrotic syndrome 1
Nephrotic syndrome 1
 
Mcd 1
Mcd 1Mcd 1
Mcd 1
 
Mcd
Mcd Mcd
Mcd
 
nephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.pptnephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.ppt
 
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptxnephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
 
Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)
 
Nephrotic syndrome in children
Nephrotic syndrome in childrenNephrotic syndrome in children
Nephrotic syndrome in children
 
Nephrotic Syndrome.pptx
Nephrotic  Syndrome.pptxNephrotic  Syndrome.pptx
Nephrotic Syndrome.pptx
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
NEPHROTIC SYNDROME IN PAEDIATRIC
NEPHROTIC SYNDROME IN PAEDIATRICNEPHROTIC SYNDROME IN PAEDIATRIC
NEPHROTIC SYNDROME IN PAEDIATRIC
 
Approach to glomerular disease.pkuwkkptx
Approach to glomerular disease.pkuwkkptxApproach to glomerular disease.pkuwkkptx
Approach to glomerular disease.pkuwkkptx
 
AGN
AGNAGN
AGN
 
Nephrotic syndrome in children
Nephrotic syndrome in childrenNephrotic syndrome in children
Nephrotic syndrome in children
 
Nephrotic syndrome dr.m.sucindar
Nephrotic syndrome   dr.m.sucindarNephrotic syndrome   dr.m.sucindar
Nephrotic syndrome dr.m.sucindar
 

More from payalgakhar

hemophilia-090722123053-phpapp02.pptx
hemophilia-090722123053-phpapp02.pptxhemophilia-090722123053-phpapp02.pptx
hemophilia-090722123053-phpapp02.pptx
payalgakhar
 

More from payalgakhar (20)

clinicalsociology and its importance in nursing
clinicalsociology and its  importance in nursingclinicalsociology and its  importance in nursing
clinicalsociology and its importance in nursing
 
population and impact importance in sociology
population and impact importance in sociologypopulation and impact importance in sociology
population and impact importance in sociology
 
accidentpreventioninchildren child health nursimg
accidentpreventioninchildren child health nursimgaccidentpreventioninchildren child health nursimg
accidentpreventioninchildren child health nursimg
 
Lymphatic System.ppt
Lymphatic System.pptLymphatic System.ppt
Lymphatic System.ppt
 
Functions of Skin.ppt
Functions of Skin.pptFunctions of Skin.ppt
Functions of Skin.ppt
 
milestone preschoolar.pptx
milestone preschoolar.pptxmilestone preschoolar.pptx
milestone preschoolar.pptx
 
Play therapy in children.pptx
Play  therapy in children.pptxPlay  therapy in children.pptx
Play therapy in children.pptx
 
g&d of infant.pptx
g&d of infant.pptxg&d of infant.pptx
g&d of infant.pptx
 
birthinjuries.ppt
birthinjuries.pptbirthinjuries.ppt
birthinjuries.ppt
 
acuterenalfailure.pptx
acuterenalfailure.pptxacuterenalfailure.pptx
acuterenalfailure.pptx
 
decision making.pptx
decision making.pptxdecision making.pptx
decision making.pptx
 
hemophilia-090722123053-phpapp02.pptx
hemophilia-090722123053-phpapp02.pptxhemophilia-090722123053-phpapp02.pptx
hemophilia-090722123053-phpapp02.pptx
 
Play therapy in children.pptx
Play  therapy in children.pptxPlay  therapy in children.pptx
Play therapy in children.pptx
 
national health progrmmes for children.pptx
national health progrmmes for children.pptxnational health progrmmes for children.pptx
national health progrmmes for children.pptx
 
Social_Stratification.pptx
Social_Stratification.pptxSocial_Stratification.pptx
Social_Stratification.pptx
 
malabsorptionsyndrome-converted.pptx
malabsorptionsyndrome-converted.pptxmalabsorptionsyndrome-converted.pptx
malabsorptionsyndrome-converted.pptx
 
thesis presentation.pptx
thesis presentation.pptxthesis presentation.pptx
thesis presentation.pptx
 
endocrinedisordersppt--converted.pptx
endocrinedisordersppt--converted.pptxendocrinedisordersppt--converted.pptx
endocrinedisordersppt--converted.pptx
 
culture.pptx
culture.pptxculture.pptx
culture.pptx
 
Thalassemia-master-Lecture-5.ppt
Thalassemia-master-Lecture-5.pptThalassemia-master-Lecture-5.ppt
Thalassemia-master-Lecture-5.ppt
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 

Recently uploaded (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 

Nephrotic_Syndrome[1].pptx

  • 2. Nephrotic syndrome Nephrotic syndrome (NS) results from increased permeability of Glomeulrar basement membrane (GBM) to plasma protein. It is clinical and laboratory syndrome characterized by massive proteinuria, which lead to hypoproteinemia ( hypo-albuminemia), hyperlipidemia and pitting edema. (4-increase, 1-decrease).
  • 3. Nephrotic Criteria:- *Massive proteinuria: qualitative proteinuria: 3+ or 4+, quantitative proteinuria : more than 40 mg/m2/hr in children (selective). *Hypo-proteinemia : total plasma proteins < 5.5g/dl and serum albumin : < 2.5g/dl. *Hyperlipidemia: serum cholesterol : > 5.7mmol/L *Edema: pitting edema in different degree
  • 4. Nephritic Criteria  -Hematuria: RBC in urine (gross hematuria)  -Hypertension:  ≥130/90 mmHg in school-age children  ≥120/80 mmHg in preschool-age children  ≥110/70 mmHg in infant and toddler’s children  -Azotemia(renal insufficiency): Increased level of serum BUN
  • 5. Classification:  A-Primary Idiopathic NS (INS): majority The cause is still unclear up to now. Recent 10 years ,increasing evidence has suggested that INS may result from a primary disorder of T– cell function. Accounting for 90% of NS in child. mainly discussed.  B-Secondary NS: NS resulted from systemic diseases, such as anaphylactoid purpura , systemic lupus erythematosus, HBV infection.  C-Congenital NS: rare *1st 3monthe of life ,only treatment renal transplantation
  • 6. Secondary NS  Drug,Toxic,Allegy: mercury, snake venom, vaccine, pellicillamine, Heroin, gold, NSAID, captopril, probenecid, volatile hydrocarbons  Infection: APSGN, HBV, HIV, shunt nephropathy, reflux nephropathy, leprosy, syphilis, Schistosomiasis, hydatid disease  Autoimmune or collagen-vascular diseases: SLE, Hashimoto’s thyroiditis,, HSP, Vasculitis  Metabolic disease: Diabetes mellitus  Neoplasma: Hodgkin’s disease, carcinoma ( renal cell, lung, neuroblastoma, breast, and etc)  Genetic Disease: Alport syn, Sickle cell disease, Amyloidosis, Congenital nephropathy  Others: Chronic transplant rejection, congenital nephrosclerosis
  • 7. Idiopathic NS (INS): Pathology:-  Minimal Change Nephropathy (MCN): <80% The glomeruli appear normal basically Under Light microscopy, and Under Immunofluorescence *under Electron microscopy – fusion of the foot processes of the podocytes  (2) Non—MCN: <20% *Mesangial proliferative glomerulonephritis (MsPGN): about 10% *Focal segmental glomerulosclerosis (FSGS): 5% *Membranous Nephropathy (MN) : 2% *Membrane proliferative glomerulonephritis  (MPGN) : 1%  *Others: rare,Cresent glomerulonephritis
  • 8.  NB:-  *Nephrotic syndrome is 15 times more common in children than in adults.  *Most cases of primary nephrotic syndrome are in children and are due to minimal-change disease. The age at onset varies with the type of nephrotic syndrome.
  • 9. Pathophysiology: The Main Trigger Of primary Nephrotic Syndrome and Fundamental and highly important change of pathophysiology :- Proteinuria
  • 10. Pathogenesis of Proteinuria:-  Increase glomerular permeability for proteins due to loss of negative charged glycoprotein  Degree of protineuria:-  Mild less than 0.5g/m2/day  Moderate 0.5 – 2g/m2/day  Sever more than 2g/m2/day  Type of proteinuria:-  A-Selective proteinuria: where proteins of low molecular weight .such as albumin, are excreted more readily than protein of HMW  B-Non selective :  LMW+HMW are lost in urine
  • 11. pathogenesis of hypoalbuminemia *Due to hyperproteinuria----- Loss of plasma protein in urine mainly the albumin. *Increased catabolism of protein during acute phase.
  • 12. pathogenesis of hyperlipidemia:- *Response to Hypoalbuminemia → reflex to liver --→ synthesis of generalize protein ( including lipoprotein ) and lipid in the liver ,the lipoprotein high molecular weight no loss in urine → hyperlipidemia *Diminished catabolism of lipoprotein
  • 13. pathogenesis of edema:-  *Reduction plasma colloid osmotic pressure↓ secondary to hypoalbuminemia Edema and hypovolemia  *Intravascular volume↓ antidiuretic hormone (ADH ) and aldosterone(ALD)  water and sodium retention Edema  *Intravascular volume↓ glomerular filtration rate  (GFR)↓ water and sodium retention  Edema
  • 14. How many pathological types causes nephrotic syndrome?
  • 15. Clinical Manifestation:- IN MCNS , The male preponderance of 2:1 : 1.Main manifestations: Edema (varying degrees) is the common symptom Local edema: edema in face , around eyes( Periorbital swelling) , in lower extremities. Generalized edema (anasarca), edema in penis and scrotum. 2-Non-specific symptoms: Fatigue and lethargy loss of appetite, nausea and vomiting ,abdominal pain , diarrhea body weight increase, urine output decrease pleural effusion (respiratory distress)
  • 16.
  • 17.
  • 18. Investigations:-  1-Urine analysis:- A-Proteinuria : b-24 urine collection for protein >40mg/m2/hr for children c- volume: oliguria (during stage of edema formation) d-Microscopically:- microscopic hematuria 20%, large number of hyaline cast
  • 19. Investigations:-  2-Blood:  A-serum protein: decrease >5.5gm/dL , Albumin levels are low (<2.5gm/dL).  B-Serum cholesterol and triglycerides: Cholesterol >5.7mmol/L (220mg/dl).  C-- ESR↑>100mm/hr during activity phase  .  3.Serum complemen: Vary with clinical type.  4.Renal function
  • 20. Complications of NS:- 1-Infections:Infections is a major complication in children with NS. It frequently trigger relapses. Nephrotic pt are liable to infection because : A-loss of immunoglobins in urine. B-the edema fluid act as a culture medium. C-use immunosuppressive agents. D- malnutrition The common infection : URI, peritonitis, cellulitis and UTI may be seen. Organisms: encapsulated (Pneumococci, H.influenzae), Gram negative (e.g E.coli
  • 21. Complication … Vaccines in NS;- polyvalent pneumococcal vaccine (if not previously immunized) when the child is in remission and off daily prednisone therapy. Children with a negative varicella titer should be given varicella vaccine.
  • 22. Complication…..  2-Hypercoagulability (Thrombosis).  Hypercoagulability of the blood leading to venous or arterial thrombosis:  Hypercoagulability in Nephrotic syndrome caused by:  1-Higher concentration of I,II, V,VII,VIII,X and fibrinogen  2- Lower level of anticoagulant substance: antithrombin III  3-decrease fibrinolysis.  4-Higher blood viscosity  5- Increased platelet aggregation  6- Overaggressive diuresis
  • 23.  3-ARF: pre-renal and renal  4- cardiovascular disease :-Hyperlipidemia, may be a risk factor for cardiovascular disease.  5-Hypovolemic shock  6-Others: growth retardation, malnutrition,  adrenal cortical insufficiency
  • 24. Management of NS:  General (non-specific )  *Corticosteroid therapy
  • 25. General therapy:-  Hospitalization:- for initial work-up and evaluation of treatment.  Activity: usually no restriction , except  massive edema,heavy hypertension and infection.  Diet Hypertension and edema: Low salt diet (<2gNa/ day) only during period of edema or salt-free diet. Severe edema: Restricting fluid intake  Avoiding infection: very important.  Diuresis: Hydrochlorothiazide (HCT) :2mg/kg.d  Antisterone : 2~4mg/kg.d  Dextran : 10~15ml/kg , after 30~60m,  followed by Furosemide (Lasix) at 2mg/kg .
  • 26. Induction use of albumin:-  Albumin + Lasix (20 % salt poor)  1-Severe edema  2-Ascites  3-Pleural effusion  4-Genital edema  5-Low serum albumin
  • 27. Corticosteroid—prednisone therapy:- Prednisone tablets at a dose of 60 mg/m2/day (maximum daily dose, 80 mg divided into 2-3 doses) for at least 4 consecutive weeks. After complete absence of proteinuria, prednisone dose should be tapered to 40 mg/m2/day given every other day as a single morning dose. The alternate-day dose is then slowly tapered and discontinued over the next 2-3 mo.
  • 28. Treatment of relapse in NS: Many children with nephrotic syndrome will experience at least 1 relapse (3-4+proteinuria plus edema). daily divided-dose prednisone at the doses noted earlier (where he has the relapse) until the child enters remission (urine trace or negative for protein for 3 consecutive days). The pred-nisone dose is then changed to alternate-day dosing and tapered over 1-2 mo.
  • 29. Side Effects With Long Term Use of Steroids “Steroid toxicity  hyperglycemia  myopathy  peptic ulcer  poor healing of wound.  Hirsutism  Thromboembolism -Stunted growth Cataracts -Osteoporosis - Cushing syndrome features -Adrenal gland suppression
  • 30. Alternative agent:-  When can be used:  Steroid-dependent patients, frequent relapsers, and steroid- resistant patients.  Cyclophosphamide Pulse steroids  Cyclosporin A  Tacrolimus  Microphenolate